G-286. FEATURES OF THE MECHANISM OF DEVELOPMENT OF PULMONARY HYPERTENSION IN PATIENTS UNDERGOING HEMODIALYSIS THROUGH ARTERIOVENOUS ACCESS:

Abstract

Pulmonary hypertension (PH) is a significant complication in ESRD patients on HD, exacerbated by AV fistulas and involving dysregulation of endothelin-1 (ET-1) and nitric oxide (NO). Aim to evaluate the role of endothelin-1 (ET-1) and nitric oxide (NO) in the development and progression of PH in patients on program hemodialysis and with AV access.